TLI Logo

Home Research Advanced Therapeutics & Biomedical Technologies

Advanced Therapeutics & Biomedical Technologies

On this Page

Our Focus

The Advanced Therapeutics & Biomedical Technologies Innovation Hub brings together The Lundquist Institute investigators to advance therapies, diagnostics, and biomedical technologies for diseases with major unmet needs. ATBT connects expertise in gene and cell therapy, regenerative medicine, genomics, biomarkers, AI-enabled diagnostics, clinical translation, and biomedical engineering to help promising discoveries move from early research toward patient impact. Rather than a single laboratory or program, our hub is a collaborative framework that helps investigators find partners, share technical expertise, build translational projects, and create stronger pathways from discovery to treatment.

Executive Directors

Paul Mathews, PhD
lynda polGreen, MD, MS

Why This Hub Exists

Many promising biomedical discoveries stall before they reach patients because the path from idea to therapy requires expertise across disease biology, technology development, preclinical testing, regulatory planning, clinical implementation, and partnership building. Our hub is designed to make those connections easier by bringing together investigators and resources across The Lundquist Institute.

check_circle

We bridge the gap between laboratory discoveries and patient care by advancing promising treatments through preclinical and clinical development. We help move innovative therapies from concept to the clinic faster and more efficiently.

check_circle_outline

We promote genomics, multi-omics, AI-enabled analysis, imaging, and biomarker approaches to improve disease detection, diagnosis, and personalized treatment decisions. By combining advanced data analysis with biomedical research, we uncover insights that lead to more precise and proactive care.

check_circle

We develop and refine cutting-edge medical devices, digital health tools, and biomedical technologies that improve how diseases are diagnosed, treated, and monitored. We collaborate across disciplines to transform scientific ideas into practical healthcare solutions.

check_circle_outline

We design innovative approaches that harness stem cells, tissue engineering, and regenerative technologies to repair, replace, or restore damaged tissues and organs. Our goal is to develop therapies that help the body heal itself and improve long-term patient outcomes.

We support research across a broad range of diseases and health challenges, including:

Ataxia-telangiectasia, Sanfilippo syndrome, mucopolysaccharidoses, achondroplasia, osteopetrosis, sickle cell disease, and other inherited disorders where new therapeutic strategies are urgently needed.

Down syndrome, Trisomy 21-associated lung disease, neonatal airway disease, lung development, newborn screening, reproductive health, and conditions affecting children and families early in life.

Neurodevelopmental disorders, cerebellar disease, cognitive dysfunction, Alzheimer’s disease and related dementias, brain tumors, and technologies to better understand brain function and disease progression.

Research focused on cancer diagnosis, disease monitoring, tumor biology, brain tumors, liquid biopsy approaches, clinical trials, and technologies that may improve treatment selection and patient outcomes.

Population-scale genomics, proteomics, metabolomics, biomarker discovery, polygenic risk, molecular risk prediction, and AI-enabled analysis to better understand disease risk, progression, and treatment response.

Hub Researchers

Labs, Centers, and Programs


The Kesari Lab

Stem cell-based Partnership Resource for Investigating Human Diseases and Training (SPRINT) Core-CIRM Shared Resources Lab


Southern California Thyroid Cancer Consortium


Contact, Collaborate and Support

Collaborate with our investigators working in therapeutics, diagnostics, biomedical technologies, and translational research.

[email protected]

Philanthropic and industry partnerships can help accelerate promising discoveries toward patient impact.

Learn how TLI investigators are working across disciplines to develop new approaches for diseases with unmet medical need.